MedTrace Logo

The Effect of Nasal Carbon Dioxide (CO2) on Nasal Congestion in Subjects With Perennial Allergic Rhinitis

NCT00638755 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2010-08-19

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of nasal CO2 on nasal congestion and other symptoms related to Perennial Allergic Rhinitis.

Conditions

  • Perennial Allergic Rhinitis

Interventions

DRUG

Nasal Carbon Dioxide

Nasal Carbon Dioxide

DRUG

Nasal Carbon Dioxide

Nasal Carbon Dioxide

DRUG

Nasal Carbon Dioxide

Nasal Carbon Dioxide

DRUG

Nasal Carbon Dioxide

Nasal Carbon Dioxide

Sponsors & Collaborators

  • Capnia, Inc.

    lead INDUSTRY

Principal Investigators

  • Capnia Clinical Study Investigator · Capnia Investigative Site

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2008-05-31
Completion
2008-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00638755 on ClinicalTrials.gov